Literature DB >> 6806219

Fifteen year radiotherapy experience with chondrosarcoma of bone.

D McNaney, R D Lindberg, A G Ayala, H T Barkley, D H Hussey.   

Abstract

A retrospective analysis of 20 patients with chondrosarcoma of bone treated for cure between 1961 and 1976 using supervoltage radiotherapy and/or neutrons is presented. Radiotherapy was used alone or in combination with other modalities. The 20 patients were divided into four groups: 1) 11 patients who received radiotherapy alone, 2) three patients who received postoperative radiotherapy following less than radical local excision, 3) three patients who received radiotherapy with chemotherapy but without surgery, and 4) three patients who received radiotherapy for tumor recurrent after surgery. Typical tumor doses ranged from 4000 to 7000 rad at 1000 rad/week using parallel-opposed fields. Failure of radiotherapy was indicated by progression of symptoms and increasing tumor size. At 53 months, the average follow-up, the survival rate is 65% (13/20), including one patient with distant metastases, and two patients who developed local recurrent disease after radiotherapy and were surgically salvaged. Seven patients died with uncontrolled local disease; six of them also had distant metastases. Five patients developed severe complications. All four patients treated with a combination of neutron and photon beam alone show no evidence of local failure, compared with only one of the seven patients treated with conventional radiotherapy alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6806219     DOI: 10.1016/0360-3016(82)90512-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  14 in total

1.  Chondrosarcoma of the head and neck.

Authors:  Sei Young Lee; Young Chang Lim; Mee Hyun Song; Jae Yeon Seok; Won Sang Lee; Eun Chang Choi
Journal:  Yonsei Med J       Date:  2005-04-30       Impact factor: 2.759

Review 2.  Chondrosarcomas of the head and neck.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Asterios Triantafyllou; Jennifer L Hunt; Juan C Fernández-Miranda; Primož Strojan; Remco de Bree; Alessandra Rinaldo; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-10       Impact factor: 2.503

3.  Chondrosarcoma in the mental foramen region of the mandible: A case report.

Authors:  Hongwei Liu; Xiuhong Chen; Teng Wan; Ren Li
Journal:  Oncol Lett       Date:  2016-07-14       Impact factor: 2.967

Review 4.  A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base.

Authors:  Maurizio Amichetti; Dante Amelio; Marco Cianchetti; Riccardo Maurizi Enrici; Giuseppe Minniti
Journal:  Neurosurg Rev       Date:  2010-04       Impact factor: 3.042

5.  Chondrosarcoma of the larynx: a case report.

Authors:  M Policarpo; F Taranto; E Aina; P Valletti Aluffi; F Pia
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-02       Impact factor: 2.124

6.  Chondrosarcomas of the head and neck.

Authors:  D S Ruark; U K Schlehaider; J P Shah
Journal:  World J Surg       Date:  1992 Sep-Oct       Impact factor: 3.352

7.  Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma.

Authors:  Kyle R Duchman; Charles F Lynch; Joseph A Buckwalter; Benjamin J Miller
Journal:  Clin Orthop Relat Res       Date:  2014-04-05       Impact factor: 4.176

8.  The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Authors:  Walter Rhomberg
Journal:  Sarcoma       Date:  2006

9.  Massive dedifferentiated chondrosarcoma affecting whole mandible with high recurrence potential.

Authors:  Niranjan Mishra; Akhilesh Kumar Singh; Rahul Agrawal; Shreya Singh
Journal:  Natl J Maxillofac Surg       Date:  2015 Jul-Dec

10.  Unresectable Extraskeletal Myxoid Chondrosarcoma of the Neck: Early Tumor Response to Chemoradiotherapy.

Authors:  Mark Zaki; Pam Laszewski; Natasha Robinette; Husain Saleh; Naweed Raza; Ammar Sukari; Harold Kim
Journal:  Cureus       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.